LesenForschungRadarAnlageframework
Anmelden / Registrieren
← Zurück zur Lektüre
NewsThema · AI药物警戒应用Wesentlich2 Min. LesezeitDisconfirmAI Redaktion

UPenn Team Uses AI to Scan Reddit for Unapproved Weight-Loss Drug Side Effects

AI extracts potential side effect signals from massive unstructured social data, demonstrating its auxiliary role in pharmacovigilance while highlighting the inability to replace clinical validation.

2026-10-20 11:10 GMT+8

A research team at the University of Pennsylvania recently published a study utilizing artificial intelligence to analyze nearly 150,000 posts and comments on the forum Reddit regarding Retatrutide, a weight-loss drug that has not yet been approved for market release. The study covers feedback from approximately 40,000 users and marks the first systematic attempt by the medical community to organize symptoms and side effects mentioned in online communities for this "gray market" drug. The results have been published in the medical journal JAMA Network Open.

The research found that among identifiable symptom descriptions, the most frequently reported reaction by netizens was actually "increased appetite." This phenomenon differs significantly from the side effect profile observed in Phase II clinical trials of Retatrutide, which were dominated by gastrointestinal discomfort. Neil Sehgal, one of the study's authors, noted that this is the first glimpse into real-world usage experiences of a drug that has not completed clinical trials nor received approval. However, researchers emphasized that this discrepancy does not prove causality through community reports and cannot serve as an alternative to clinical trial evidence.

The core value of this case lies in demonstrating AI's potential to process complex, unstructured data. Through natural language processing, AI can uncover data patterns worth further investigation from vast amounts of daily discussion. Although Reddit samples suffer from limitations such as self-selection and self-reporting, requiring cautious interpretation by the public, these AI-discovered clues are viewed as new starting points for public health and drug safety research. For readers interested in the boundaries of AI applications, this proves AI's capability to extract weak signals from noise, while also clarifying its role as a "clue finder" rather than a "final arbiter" in the scientific verification chain.

Anmelden / Registrieren
LesenForschungRadarAnlageframework

Quellen

  • technews.tw↗
Thema

AI药物警戒应用

人工智能正从实验室走向药物安全监测一线,成为捕捉传统临床试验难以发现的副作用信号的关键工具。2026年5月,美国宾夕法尼亚大学团队利用AI分析Reddit上逾40万条关于GLP-1减肥药(如Ozempic)的帖子,识别出月经异常、寒战等未被…

3 Schritte2 BeiträgeAktualisiert 2026-10-21 04:51

Wie es dazu kam

  1. 2026-05-24美国宾夕法尼亚大学研究团队在《Nature Health》发表成果,利用AI分析超过40万条Reddit帖子,发现GLP-1类药物用户频繁讨论月经不规则、寒战等未在临床试验中充分反映的症状。sciencedaily.com ↗
  2. 2026-10-20同一宾大团队在《JAMA Network Open》发文,展示AI如何扫描近15万条Reddit贴文,从未获批减肥药Retatrutide的使用反馈中提取出“食欲增加”这一与二期试验结果不同的副作用信号。technews.tw ↗
  3. 2026-10-20美国麻省总医院Brigham癌症研究所Ray Mak团队在《Lancet Digital Health》发布FAHR-Face模型,该模型可通过单张面部照片预测癌症患者死亡风险,但因训练集以白人为主且存在伦理争议,目前未投入临床。scientificamerican.com ↗

Was noch ungeklärt ist

  • AI从社交媒体提取的信号如何转化为监管认可的正式安全性更新?
  • 面部照片预测模型在扩大种族多样性后,其临床准确性与伦理边界将如何界定?
  • 欧盟IHI拟议的AI药物警戒标准何时能形成具有约束力的指导文件?

Auch in diesem Thread

  • US Mass General Brigham Team Develops AI Model That Predicts Cancer Death Risk from Face Photos2026-10-20
Vollständiges Thema lesen →
Recherche fortsetzen →